20081 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Excipients; Inactive ingredients Inorganic compounds
COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
#902Compositions for pulmonary delivery of long-acting βadrenergic receptor agonists and associated methods and systems
#903PROCESS FOR PREPARING ORALLY ADMINISTERED DABIGATRAN FORMULATIONS
#904Porous drug matrices and methods of manufacture thereof
#905Administrable compositions
#906Polymer microgel beads and preparative method thereof
#907SELF-MICROEMULSIFYING SYSTEMS INCORPORATED INTO LIQUID CORE MICROCAPSULES
#908Moisture resistant container systems for rapidly bioavailable dosage forms
#909Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
#910Granular compositions of magnesium oxide and citric acid and uses thereof
#911Composition for rapid disintegrating tablet in oral cavity
#912Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
#913DELIVERY SYSTEM FOR AN ACTIVE INGREDIENT
#914ORALLY DISINTEGRABLE TABLETS
#915Local system for the release of active principle and process for its manufacture
#916Formulations comprising linaclotide
#917Methods, Compositions and Devices for Treating Lesioned Sites Using Bioabsorbable Carriers
#918Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems
#919Solid dispersion and pharmaceutical composition of the same, and production processes thereof
#920PHARMACEUTICAL COMPOSITIONS
#921Pharmaceutical Polypeptide Dry Powder Aerosol Formulation and Method of Preparation
#922Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
#923Self-microemulsifying drug delivery systems
#924Respiratory dispersion for metered dose inhalers comprising perforated microstructures
#925Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
#926Pharmaceutical formulation containing choline alfoscerate
#927Polyinosinic acid-polycytidylic acid-based adjuvant
#928MILNACIPRAN FORMULATIONS
#929GRANULES, TABLETS AND METHOD OF PRODUCING THE SAME
#930SPACE FILLED DRUG RELEASE STRUCTURE AND METHOD OF MANUFACTURING THE SAME
#931Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#932Formulations and methods for lyophilization and lyophilates provided thereby
#933METHOD FOR STABLE AND CONTROLLED DELIVERY OF (-)-HYDROXYCITRIC ACID
#934Composition Comprising Desmopressin
#935Pulmonary delivery particles comprising an active agent
#936RADIOLABELLED MICROPARTICLES, PROCESSES FOR THE PREPARATION THEREOF AND THE USE THEREOF
#937Pharmaceutical formulation containing irritant
#938Core particle for pharmaceutical preparation
#939Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
#940Controlled release matrix pharmaceutical dosage formulation
#941Slow-release pharmaceutical formulation and process for its preparation
#942METHOD FOR PRODUCING GRANULATED PREPARATION
#943Method of drug formulation of compositions comprising crystalline microparticle surfaces
#944Composition for foodstuff for binding acetaldehyde
#945Misuse preventative, controlled release formulation
#946Microspheres and their methods of preparation
#947METHODS AND PHARMACEUTICAL FORMULATIONS FOR PROTECTING PHARMACEUTICAL COMPOUNDS FROM ACIDIC ENVIRONMENTS
#948Animal lesion treatment and prevention formulations and methods
#949GRANULE, TABLET AND METHODS FOR PRODUCING THE SAME
#950Method of Producing Porous Microparticles
#951Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate
#952Methods, Compositions and Devices for Treating Lesioned Sites Using Bioabsorbable Carriers
#953MEDICINAL FORMS OF PHOSPHOLIPID PREPARATIONS AND METHODS FOR THEIR PREPARATION
#954Pharmaceutical preparations containing highly volatile silicones
#955Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
#956Micro-particles, blood-substitute and method for forming same
#957Rare earth metal compounds, methods of making, and methods of using the same
#958Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt
#959Systems, devices, and methods for making or administering frozen particles
#960Systems, devices, and methods for making or administering frozen particles
#961Medicinal forms of phospholipid preparations and methods for their preparation
#962Preparation for transnasal application
#963PATHOGENIC ATTENUATION VIA THE ADMINISTRATION OF AN EQUILIBIOTIC COMPOUND
#964Pharmaceutical Compositions for the Coordinated Delivery of Naproxen and Esomeprazole
#965Systems, devices, and methods for making or administering frozen particles
#966Easily Absorbable Oral Preparations of Xanthine Derivatives
#967Systems, devices, and methods for making or administering frozen particles
#968Systems, devices and methods for making or administering frozen particles
#969Frozen compositions and methods for piercing a substrate
#970METHOD OF PREPARING SOLID DOSAGE FORMS OF MULTI-PHASIC PHARMACEUTICAL COMPOSITIONS
#971PALONOSETRON FORMULATION
#972Frozen compositions and methods for piercing a substrate
#973Hemophilia Treatment by Inhalation of Coagulation Factors
#974Frozen compositions and methods for piercing a substrate
#975Frozen compositions and array devices thereof
#976Compositions and methods for biological remodeling with frozen particle compositions
#977Frozen compositions and methods for piercing a substrate
#978PHARMACEUTICAL COMPOSITIONS STABILISED IN GLASSY PARTICLES
#979Compositions and methods for delivery of frozen particle adhesives
#980Compositions and methods for delivery of frozen particle adhesives
#981Compositions and methods for therapeutic delivery with frozen particles
#982Compositions and methods for biological remodeling with frozen particle compositions
#983Compositions and methods for biological remodeling with frozen particle compositions
#984Compositions and methods for surface abrasion with frozen particles
#985Frozen piercing implements and methods for piercing a substrate
#986Frozen compositions and methods for piercing a substrate
#987Compositions and methods for administering compartmentalized frozen particles
#988Compositions and methods for administering compartmentalized frozen particles
#989Compositions and methods for administering compartmentalized frozen particles
#990Compositions and methods for administering compartmentalized frozen particles
#991Compositions and methods for delivery of frozen particle adhesives
#992Compositions and methods for therapeutic delivery with frozen particles
#993Compositions and methods for therapeutic delivery with frozen particles
#994Compositions and methods for therapeutic delivery with frozen particles
#995Compositions and methods for therapeutic delivery with frozen particles
#996Compositions and methods for surface abrasion with frozen particles
#997Compositions and methods for biological remodeling with frozen particle compositions
#998Compositions and methods for therapeutic delivery with frozen particles
#999Compositions and methods for therapeutic delivery with frozen particles
#1000Compositions and methods for therapeutic delivery with frozen particles
#1001Compositions and methods for surface abrasion with frozen particles
#1002Compositions and methods for surface abrasion with frozen particles
#1003TREATMENT OF INFLAMMATORY AND/OR BACTERIAL CONDITIONS WITH PARTICLES OF MICROSTRUCTURE
#1004Method of producing porous microparticles
#1005Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
#1006MONOLITHIC DRUG DELIVERY SYSTEM
#1007Functionalized calcium phosphate hybrid systems for confectionery and foodstuff applications
#1008Active ingredient delivery system with an amorphous metal salt as carrier
#1009COMPLEX FORMULATION FOR PREVENTING OR TREATING OSTEOPOROSIS WHICH COMPRISES SOLID DISPERSION OF VITAMIN D OR ITS DERIVATIVE AND BISPHOSPHONATE
#1010Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration
#1011Methods of processing compositions containing microparticles
#1012SOLUBILIZED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
#1013Spray drying process control of drying kinetics
#1014Effervescent tablets/granules
#1015Grinding method for the manipulation or preservation of calcium phosphate hybrid properties
#1016CONTROLLED RELEASE COMPOSITION AND PROCESS
#1017SOLID DISPERSION OF A NEUROKININ ANTAGONIST
#1018Hydrocolloid carrier beads with inert filler material
#1019Solid dispersions comprising tacrolimus
#1020COMPOSITION AND COMBINATIONS OF CARBOXYLIC ACID LOSARTAN IN DOSAGE FORMS
#1021Use of solid carrier particles to improve the processability of a pharmaceutical agent
#1022Water-insoluble, iron-containing mixed metal, granular material
#1023USE OF ROLL COMPACTED PYROGENICALLY PRODUCED SILICON DIOXIDE IN PHARMACEUTICAL COMPOSITIONS
#1024Pellet Formulation Comprising Colloidal Silicon Dioxide
#1025Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions
#1026DRUG DELIVERY COMPOSITION
#1027Formulations, devices and methods for treating and preventing mucositis
#1028Systems and processes for spray drying hydrophobic and hydrophilic components
#1029Therapeutic formulation
#1030Microencapsulation and sustained release of biologically active polypeptides
#1031System for the liberation of an active principle and its use
#1032Pre-compacted calcium-containing compositions
#1033Spray-drying process for the manufacture of dye-loaded particles
#1034Stabilized solid medicinal forms containing active ingredient and method for the production thereof
#1035Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
#1036FORMULATIONS FOR POORLY PERMEABLE ACTIVE PHARMACEUTICAL INGREDIENTS
#1037DEXLANSOPRAZOLE COMPOSITIONS
#1038COMPOSITION AND METHOD FOR BINDING ACETALDEHYDE IN STOMACH
#1039Controlled release of biological entities
#1040Particles having hydrophobic material therein
#1041Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
#1042Controlled release delivery device comprising an organosol coat
#1043Solid Formulations
#1044Orally Disintegrating Tablets
#1045Porous photonic crystals for drug delivery to the eye
#1046PHARMACEUTICAL COMPOSITIONS OF ATORVASTATIN
#1047PHARMACEUTICAL COMPOSITIONS
#1048Taste titration therapies
#1049METHOD FOR STABILIZATION OF ISOXAZOLE COMPOUND
#1050PHARMACEUTICAL COMPOUND TO PREVENT AND TREAT FOCAL TISSULAR LESIONS AND INFECTIONS, METHOD AND APPLICATORS
#1051PHARMACEUTICAL COMPOSITION CONTAINING LEVODOPA, ENTACAPONE AND CARBIDOPA
#1052Microemulsion containing indolocarbazole compound and dosage forms containing the same
#1053PHARMACEUTICAL PRODUCT
#1054Intestinal absorptive anti-tumor agent
#1055Hydroxyapatite calcium phosphates, their method of preparation and their applications
#1056Granular preparation containing biguanide compound
#1057Pharmaceutical compositions
#1058ORAL DOSAGE FORM OF CEFTRIAXONE AND METHODS OF USE
#1059Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase
#1060Bioresorbable controlled-release composition
#1061CONTROLLED RELEASE SOLID PREPARATION
#1062PHARMACEUTICAL SOLID HYBRIDS
#1063Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same
#1064Pharmaceutical Compositions of Amorphous Atorvastatin and Process for Preparing Same
#1065METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS
#1066Orally disintegrating tablets
#1067Spray-Drying process for producing a dry caritine powder or granulate
#1068Dosage Forms Containing A PPI, NSAID And A Buffer
#1069Dosage Forms Containing A PPI, NSAID And A Buffer
#1070ORAL RAPID RELEASE PHARMACEUTICAL FORMULATION FOR PYRIDYLMETHYLSULFINYL-BENZIMIDAZOLES
#1071CARRIERS FOR DRUG DELIVERY
#1072Phospholipid-based powders for drug delivery
#1073Delayed release formulations of 6-mercaptopurine
#1074Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration
#1075Composition comprising biodegradable hydrating ceramics for controlled drug delivery
#1076Storage stable powder compositions of interleukin-4 receptor
#1077Novel Substituted Benzimidazole Dosage Forms and Method of Using Same
#1078Drug carrier pellet production process
#1079Nucleic acid microparticles for pulmonary delivery
#1080Pharmaceutical compositions for gastrointestinal drug delivery
#1081Particulate Compositions Comprising Alginate and/or Alginic Acid
#1082STRONTIUM FORTIFIED CALCIUM NANO-AND MICROPARTICLE COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
#1083Storage-Stable Oral Dosage Form of Amoxicillin and Clavulanic Acid
#1084Pharmaceutical compositions of adsorbates of amorphous drug
#1085Orally disintegrable tablets
#1086Immunogenical complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica
#1087Sesamin/Episesamin Compositions
#1088Stable Granulates Containing S-adenosylmethionine and Process for Preparation Thereof
#1089Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
#1090Solid Oral Dosage Forms of Ziprasidone Containing Colloidal Silicone Dioxide
#1091Pulmonary Formulation
#1092Particulate Lipid Pharmaceutical Composition
#1093Micropellet Containing Pellets and Method of Preparing Such Pellets
#1094Pharmaceutical Compositions Comprising Danazol
#1095TARGETED ACTIVE AGENT DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES
#1096Formulations for spray-drying large porous particles
#1097Dispersion for pulmonary delivery of a bioactive agent
#1098Method of Production of Fine-Crystalline Mixture Containing Non-Steroid Anti-Inflammatory Drug, Fine-Crystalline Mixture Obtainable by this Method and Solid Pharmaceutical Composition Containing this Mixture
#1099Abuse Resistant Opioid Transdermal Delivery Device Containing Opioid Antagonist Microspheres
#1100Respiratory dispersion for metered dose inhalers
#1101Controlled release system and manufacturing method thereof
#1102Pharmaceutical Composition Containing Indometacin and/or Acemetacin
#1103Therapeutic Agent for Bh4-Responsive Hyperphenylalaninemia
#1104Process For Preparing Granulates Comprising Amoxicillin
#1105Spray Dried Compositions
#1106DISINTEGRATION PROMOTERS IN SOLID DOSE WET GRANULATION FORMULATIONS
#1107pKa buffered vitamin C composition and method
#1108Taste masked dosage form containing roflumilast
#1109Dosage form with improved release of cefuroximaxetil
#1110Hybrid organic/inorganic chemical hybrid systems, including functionalized calcium phosphate hybrid systems, and a solid-state method for producing the same
#1111COMPRESSIBLE SOLID PARTICLES, PROCEDURES FOR THE OBTENTION THEREOF AND PROCEDURES FOR THE USE OF SAID PARTICLES IN BODY-CLEANSING TABLETS
#1112Antitumor Agent
#1113USE OF 5HT4 RECEPTOR ANTAGONISTS IN THE PROPHYLAXIS OR TREATMENT OF CERTAIN CARDIOVASCULAR CONDITIONS
#1114Base Forming Drug-Layered Silicate Hybrid Containing Basic Polymer and its Synthesis Method
#1115Medical Device and Its use
#1116CONTROLLED RELEASE CERAMIC PARTICLES, COMPOSITIONS THEREOF, PROCESSES OF PREPARATION AND METHODS OF USE
#1117Ramipril formulation
#1118Ramipril formulation
#1119Method and apparatus for producing dry particles
#1120Particles for cell targeting
#1121Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor
#1122Amorphous ezetimibe and the production thereof
#1123Antitumor Composition
#1124Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
#1125METHODS, COMPOSITIONS AND DEVICES FOR TREATING LESIONED SITES USING BIOABSORBABLE CARRIERS
#1126Fast release dosage forms for antibiotics
#1127Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
#1128Process for the Preparation of a Solid, Orally Administrable Pharmaceutical Composition
#1129Solid Dosage Form Comprising Proton Pump Inhibitor and Suspension Made Thereof
#1130AZITHROMYCIN DOSAGE FORMS WITH REDUCED SIDE EFFECTS
#1131Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
#1132Fibrin adhesive granulate and method for its preparation
#1133Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
#1134Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
#1135Therapeutic calcium phosphate particles and methods of manufacture and use
#1136Controlled agglomeration
#1137Controlled release delivery system for bio-active agents
#1138Magnetically Targetable Mitomycin C Compositions and Methods of Their Use
#1139Ramipril formulation
#1140Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers
#1141Microspheroidal Controlled Release Of Biomolecules
#1142Dosage Forms Containing A PPI, NSAID, and Buffer
#1143Solid Pharmaceutical Preparation for Dialysis
#1144Controlled Release Matrix Pharmaceutical Dosage Formulation
#1145Dispersion for pulmonary delivery of a bioactive agent
#1146Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
#1147Andrographis Extract Formulations
#1148PHARMACEUTICAL COMPOSITION
#1149Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
#1150Pantoprazole multiparticulate formulations
#1151Pantoprazole multiparticulate formulations
#1152Method for preparing adjustably bioresorbable sol-gel derived SiO
#1153LOCAL SYSTEM FOR THE RELEASE OF ACTIVE PRINCIPLE AND PROCESS FOR ITS MANUFACTURE
#1154Method of preparing hydroxyapatite based drug delivery implant for infection and cancer treatment
#1155Moisture resistant container systems for rapidly bioavailable dosage forms
#1156Blister packaging for acute pain regimens
#1157Compositions containing solid ibuprofen concentrates and methods of making solid ibuprofen concentrates
#1158Biguanide formulations
#1159Polyinosinic acid-polycytidylic acid-based adjuvant
#1160Parathyroid hormone (pth) containing pharmaceutical compositions for oral use
#1161Spray-dried collectin compositions and process for preparing the same
#1162Pharmaceutical compositions of adsorbates of amorphous drug
#1163Composition containing medicine extremely slightly soluble in water and method for preparation thereof
#1164Compositions comprising amphotericin B, mehods and systems
#1165High load particles for inhalation having rapid release properties
#1166COMPOSITIONS AND METHODS FOR THE PULMONARY DELIVERY OF AEROSOLIZED MEDICAMENTS
#1167Storage stable power compositions of interleukin-4 receptor
#1168STABLE PHARMACEUTICAL COMPOSITIONS
#1169Wet granulation process
#1170Pharmaceutical compositions comprising lercanidipine
#1171Process for making ceramic, mineral, and metal beads from powder
#1172Ramipril Formulation
#1173Banded controlled release nanoparticle active agent formulation dosage forms and methods
#1174EFFERVESCENT FORMULATIONS COMPRISING APOMORPHINE
#1175ORAL FORMULATION OF CREATINE DERIVATIVES AND METHOD OF MANUFACTURING SAME
#1176Composite material comprising a porous semiconductor impregnated with an organic substance
#1177Novel controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
#1178Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
#1179Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#1180System for the liberation of an active principle and its use
#1181Process for co-spray drying liquid herbal extracts with dry silicified MCC
#1182Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments
#1183Pantoprazole multiparticulate formulations
#1184Particulate vitamin composition
#1185Methods to regulate polarization of excitable cells
#1186Microencapsulation and sustained release of biologically active polypeptides
#1187Method of producing dosage units of a solid drug form containing warfarin sodium salt as active component
#1188Botulinum toxin compositions
#1189Tannate compositions, methods of making and methods of use
#1190Pharmaceutical formulation containing irritant
#1191USE OF 5HT4 RECEPTOR ANTAGONISTS IN THE PROPHYLAXIS OR TREATMENT OF CERTAIN CARDIOVASCULAR CONDITIONS
#1192PHARMACEUTICAL COMPOSITIONS COMPRISING FENOFIBRATE AND ATORVASTATIN
#1193Encapsulation of water soluble peptides
#1194Compositions comprising fenofibrate and atorvastatin
#1195Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
#1196Porous silica having substance carried thereon
#1197Composition containing medicine extremely slightly soluble in water being excellent in eluting property and method for preparation thereof
#1198Drug delivery device
#1199Modified release compositions comprising tacrolimus
#1200STABLE GRANULATES CONTAINING S-ADENOSYLMETHIONINE AND PROCESS FOR PREPARATION THEREOF